MEDIFIRST SOLUTIONS UPDATES SHAREHOLDERS
February 24 2017 - 11:00AM
InvestorsHub NewsWire
Freehold, NJ -- February 24, 2017 -- InvestorsHub NewsWire
-- MEDIFIRST SOLUTIONS, INC. (OTCQB:
MFST) (the “Company” or “Medifirst”) would like to update
shareholders in order to follow up on its Time Machine Conference
in Morocco, as well as to provide recent Company developments
regarding its FDA cleared Infrared Time Machine TTML-8102000 Laser
Thermal Therapeutic Device.
Medifirst is pleased to announce that it satisfied all the vendor
registration requirements and have received a Client Approved
status for the Mayo Clinic. Commented President Bruce J.
Schoengood, “We are very pleased with being accepted as a vendor
for such a prestigious and leading medical organization.”
Mayo Clinic is a nonprofit medical practice and medical research
group based in Rochester, Minnesota. It employs more than 4,500
physicians and scientists and 57,100 allied health staff. The
practice specializes in treating difficult cases through tertiary
care. It spends over $660 million a year on research.
The Company anticipates announcing, in the upcoming days, the
appointment of a New York City Medical Director for the Time
Machine Laser. This doctor and his practice, located on Central
Park South, will serve as a training facility and a conduit to the
Tri-State medical community to introduce and offer further services
regarding the laser technology. Additionally, the Company will be
hosting a private event to introduce its lasers to New York
City-based physicians and healthcare professionals. Medifirst
anticipates further details to be announced in the upcoming days
and weeks.
Medifirst recently returned from Morocco, Dubai and France where
the Company presented its technology to distributors and medical
professionals from several countries. Commented President Bruce J.
Schoengood, “The response has been overwhelming and we are working
diligently to complete our negotiations and additional
demonstrations, which involve ongoing meetings in the Mid-East,
Africa and Europe. Medifirst would like to thank all the medical
professionals we met in Morocco, Dubai and France.” A number of
healthcare companies in different countries have requested to be
distributors for the Company’s laser technology. Upon completion of
a successful negotiation, Medifirst hopes to enter into an
exclusive distribution agreement for a Morocco-based medical and
healthcare distributor in the upcoming days. Additionally,
Medifirst is in final negotiations, which if successful, involve
bulk sales, with a London-based entrepreneur for representation in
11 countries to distribute the Time Machine Laser and ongoing
negotiating continue with a Saudi-based medical distributor.
Medifirst will update shareholders as soon as all negotiations and
agreements are completed as to the final results in terms of sales
and distribution. Medifirst continues presenting and working
with individual practitioners for individual sales overseas and in
the US, which efforts are focused on generating short term revenues
and establishing Time Machine ambassadors for longer term
growth. Continued Schoengood, “We know everyone is anxious
for sales and great success and we are working as expeditiously as
possible to complete all the current deals and continue to expand
our sales force and infrastructure for both US and international
sales.”
Medifirst anticipates a shift in its current strategy to increase
its product portfolio through upcoming acquisitions. Exclusive
licensing deals are very valuable but owning specific intellectual
property which include trademarks, patents and all related IP,
would provide more security as well as increased value to the
Company. The company anticipates a rollout of additional products
in 2017.
About Medifirst Solutions, Inc.
Medifirst Solutions, Inc., in response to its Premarket
Notification 510(k) submission for “The Time Machine” Series Laser,
received clearance from the U.S. Food and Drug Administration
(“FDA”) to market its infrared Time Machine TTML-8102000 Laser
Thermal Therapeutic Device. The Time Machine Series Lasers Model
TTML-8102000 - 810/830nm is intended for use in temporary relief of
minor muscle and joint pain, stiffness, minor arthritis pain,
muscle spasm, temporary increase in local blood circulation and
temporary relaxation of muscles by means of topical elevated tissue
temperature from infrared spectral emissions. Due to the
decrease of inflammation, patients have seen immediate aesthetic
improvements as well, such as in scar and incision healing. The
hand-held laser device, with pin-point accuracy, often gives
patients immediate results with no redness, swelling or down-time.
This unique laser device offers medical professionals an affordable
and effective tool to enhance their treatment protocols for their
patients and provide new revenue streams for their practice. The
laser division will be operated out of Medifirst's wholly owned
subsidiary, Medical Lasers Manufacturer. Visit
www.medifirstsolutions.com for more information. Follow on Twitter
@Medi_First and for Facebook visit Medifirst Solutions.
Forward-Looking Statements:
The statements in this press release that relate to the company's
expectations with regard to the future impact on the company's
results from new products in development are forward-looking
statements, and may involve risks and uncertainties, some of which
are beyond our control. Such risks and uncertainties are
described in greater detail in our filings with the U.S. Securities
and Exchange Commission. Since the information in this press
release may contain statements that involve risk and uncertainties
and are subject to change at any time, the company's actual results
may differ materially from expected results. We make no
commitment to disclose any subsequent revisions to forward-looking
statements. This release does not constitute an offer to sell or a
solicitation of offers to buy any securities of any entity.
Contact: Investor Relations
Phone: (732) 786-8044
Email: admin@medifirstsolutions.com
Website: www.medifirstsolutions.com